Chroscinski Denise, Sampey Darryl, Hewitt Alex
Noble Life Sciences, Gaithersburg, United States.
BioFactura, Frederick, United States.
Elife. 2014 Dec 10;3:e04180. doi: 10.7554/eLife.04180.
The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered Report describes the proposed replication plan of key experiments from "Melanoma genome sequencing reveals frequent PREX2 mutations" by Berger and colleagues, published in Nature in 2012 (Berger et al., 2012). The key experiments that will be replicated are those reported in Figure 3B and Supplementary Figure S6. In these experiments, Berger and colleagues show that somatic PREX2 mutations identified through whole-genome sequencing of human melanoma can contribute to enhanced lethality of tumor xenografts in nude mice (Figure 3B, S6B, and S6C; Berger et al., 2012). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.
“癌症生物学可重复性项目”旨在通过对2010年至2012年间发表的50篇癌症生物学领域论文进行重复实验,来回应科学界对科研可重复性日益增长的担忧。本注册报告描述了对伯杰及其同事于2012年发表在《自然》杂志上的论文“黑色素瘤基因组测序揭示频繁的PREX2突变”(伯杰等人,2012年)中关键实验的拟重复计划。将要重复的关键实验是图3B和补充图S6中报告的实验。在这些实验中,伯杰及其同事表明,通过对人类黑色素瘤进行全基因组测序鉴定出的体细胞PREX2突变,可导致裸鼠体内肿瘤异种移植物的致死率增加(图3B、S6B和S6C;伯杰等人,2012年)。“癌症生物学可重复性项目”是开放科学中心和科学交流中心之间的合作项目,重复实验的结果将由《eLife》杂志发表。